Vireka

Sources & trust

Built on public sources, read carefully.

Vireka reads the sources below and assembles them into one dossier per molecule. How they are combined, checked and graded is our own work. Each source remains the property of its publisher and is used under its own terms; we link back so you can read the original.

Regulators & approvals

  • U.S. FDA — Drugs@FDA, drug labels, Orange Book, Purple Book, published complete response letters, drug-shortage list
  • DailyMed (U.S. National Library of Medicine)
  • European Medicines Agency — medicines register (EPARs, CHMP opinions, PRIME, orphan, conditional approvals)
  • Health Canada — Drug Product Database
  • RxNorm (U.S. National Library of Medicine)
  • EU Clinical Trials Information System (CTIS)
  • Open Targets Platform

Clinical trials & evidence

  • ClinicalTrials.gov
  • PubMed (U.S. National Library of Medicine)
  • Europe PMC — journals, preprints and congress abstracts
  • FDA Adverse Event Reporting System via openFDA

Access, pricing & reimbursement

  • Official price lists — France (BDPM), Spain (Nomenclátor), Denmark (Medicinpriser), England (NHSBSA)
  • Medicaid NADAC and Medicare Part D spending (CMS)
  • ECB euro reference exchange rates
  • NICE (England)
  • Scottish Medicines Consortium
  • Gemeinsamer Bundesausschuss — G-BA (Germany)
  • Haute Autorité de santé — HAS (France)
  • Institute for Clinical and Economic Review — ICER (U.S.)

Company & market

  • SEC EDGAR — filings and structured financial data
  • Company-reported revenue for U.S. and foreign filers
  • Investor discussion (StockTwits)
  • Market quotes (Finnhub)

Patents & litigation

  • FDA Orange Book and Purple Book patent and exclusivity listings
  • U.S. federal court dockets via CourtListener (Free Law Project)

News & events

  • Global news (Google News, GDELT)
  • Medical-congress calendars

How we keep it honest

Know a public source we should read? Tell us. · Terms · Privacy